- DOTA (also
known as
tetraxetan) is an
organic compound with the
formula (CH2CH2NCH2CO2H)4. The
molecule consists of a
central 12-membered
tetraaza (i.e...
-
Lutetium (177Lu)
vipivotide tetraxetan, sold
under the
brand name Pluvicto, is a
radiopharmaceutical medication used for the
treatment of prostate-specific...
-
Yttrium (90Y)
clivatuzumab tetraxetan (trade name hPAM4-Cide) is a
humanized monoclonal antibody-drug
conjugate designed for the
treatment of pancreatic...
-
Lilotomab (formerly tetulomab, HH1) is a
murine monoclonal antibody against CD37, a
glycoprotein which is
expressed on the
surface of
mature human B cells...
-
Yttrium (90Y)
tacatuzumab tetraxetan is an
investigational humanized monoclonal antibody intended for the
treatment of cancer. The
antibody itself, tacatuzumab...
- tyrosine3-octreotate, an SSR agonist, and the
bifunctional chelator DOTA (
tetraxetan). SSRs are
found with high
density in
numerous malignancies, including...
-
Cantuzumab ravtansine§
Cirmtuzumab Citatuzumab bogatox§
Clivatuzumab tetraxetan Cofetuzumab pelidotin Dacetuzumab§ Demcizumab§ Dalotuzumab§ Denintuzumab...
- LuAg and
lutetium iodide scintillators.
Lutetium (177Lu)
vipivotide tetraxetan is a
therapy for
prostate cancer, FDA
approved in 2022. Like
other rare-earth...
-
Structure of DOTA, also
known as
tetraxetan...
- (INN)
Yondelis Yonsa Yorvipath Yselty Yttriga yttrium (Y 90)
clivatuzumab tetraxetan (USAN)
yttrium (Y 90)
ibritumomab tiuxetan (INN)
yttrium bromatum yttrium...
